Profilo società
Financière de Tubize S.A. is a holding company that owns 36.27% of the listed biopharmacy group UCB.
Dirigenti principali
| Chief Executive Officer | |
| Head of Investor Relations | |
| Deputy General Manager |
Dati principali
| Millenium | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Investments revenues | 13 | 8 | |||
| Payroll | |||||
| Operating income | -2.236 | -2.144 | -1.823 | 381.086 | 261.493 |
| Capital gain from disposals | |||||
| Income tax | |||||
| Net income | 90.104 | 88.151 | 85.170 | 380.090 | 260.519 |
| Net income (Group share) | 90.104 | 88.151 | 85.170 | 380.090 | 260.519 |
| Fiscal year end | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
| Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
| Account Standards | Local GAAP | Local GAAP | Local GAAP | IFRS | IFRS |
Informazioni sull'azionariato
| Other shareholders | |
| Financière Eric Janssen SRL | |
| Daniel Janssen | |
| Altai Invest SA | |
| Barnfin SA |
Indirizzo
Financière de Tubize S.A.
Allée de la Recherche 60
BE-1070 Bruxelles
Belgium
Numero di telefono: +32 (0)497 51 52 08
http://www.financiere-tubize.be
Contatti
Per supporto nell'aggiornamento del company profile: MyQuestion.Italy@euronext.com.